I’ve chatted with several Avandia lawyers about the fact that the FDA isn’t allowing anyone else to enroll in the TIDE study:
WEDNESDAY, July 21 (HealthDay News) — No new patients will be permitted to enroll in a safety study of the controversial diabetes drug Avandia until further notice, the U.S. Food and Drug Administration announced Wednesday.
But under the partial clinical trial hold, those patients already enrolled in the TIDE (Thiazolidinedione Intervention With Vitamin D Evaluation) trial will be allowed to continue to participate, the agency said in a news release.
The Avandia lawyers I’ve spoken to are confident that the FDA will eventually pressure GSK to withdraw Avandia from the market. Some lawyers have gone so far as to dub Avandia to be the “Son of Vioxx.”
If you had a heart attack while taking Avandia, contact me and I’ll put you in touch with an Avandia lawyer.